Page 2 - Fibrogen China News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fibrogen china. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fibrogen China Today - Breaking & Trending Today

FibroGen Reports Third Quarter 2023 Financial Results

Topline data from two pivotal pamrevlumab pancreatic cancer trials on track to read out in 1H 2024, including the Pancreatic Cancer Action Network (PanCAN) Precision PromiseSM Phase 2/3 study in metastatic pancreatic cancer Third quarter net revenue of $40.1 million, an increase of 155% year over year Roxadustat sNDA accepted in China for chemotherapy-induced anemia Robust roxadustat volume growth of 37% in ChinaStrong execution of cost reduction plan reaffirming cash runway into 2026 SAN FRANCI ....

United States , South Africa , Meichiel Keenan , David Delucia , Society For Immunotherapy Of Cancer Annual Meeting , Corporate Communications , Fibrogen Inc , Exchange Commission , European Society For Medical Oncology Congress , Drug Administration , Pancreatic Cancer Action Network Pancan Precision Promise , China Health Authority , American Society Of Nephrology , Pancreatic Cancer Action Network , Thane Wettig , Chief Executive Officer , Key Events , Third Quarter , Chief Executive , New Drug Application , European Society , Medical Oncology Congress , American Society , Kidney Week , Cancer Annual Meeting , Fibrogen China ,

FibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Good day, and thank you for standing by. Welcome to the FibroGen’s Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s […] ....

United States , Djuan Graham , John Hunter , Fortis Therapeutics , Pet Imaging Agent , Fibrogen China , Morgan Stanley Tactical Value , Cancer Action Network , Span Can , Precision Promise , Artificial Intelligence Stocks Under , Pancreatic Cancer , John Hunter , Djuan Graham , Thane Wettig , Commercial Results ,